101513-77-3Relevant articles and documents
Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N. Gonorrhoeae infections
Betson, Mark,Bingham, Matilda,Doyle, Paul,Hallworth, Sebastian,Harvey, Rebecca,Huxley, Anthony,Kirk, Ralph,Moat, John,Nelson, Gary,Pesnot, Thomas,Tait, Michael
, (2020)
Delafloxacin, a fourth-generation anionic fluoroquinolone (FQ) was approved in 2019 for community acquired bacterial pneumonia (CARP). It has broad spectrum activity and an improved class-related toxicity profile. However, it has recently failed a Phase 3
A 2, 4, 5 - trifluoro -3 - chlorobenzoic acid preparation method
-
, (2019/02/13)
The invention discloses a 2, 4, 5 - trifluoro - 3 - chlorobenzoic acid preparation method, which belongs to the chemical pharmaceutical intermediates preparation method technical field, the use of 1, 2, 4, - trifluorobenzene as raw materials, by nitration, chloro, re-nitration, reduction, diazotization, cyanide Sandmeyer reaction and hydrolysis reaction for preparing 2, 4, 5 - trifluoro - 3 - chlorobenzoic acid. The method of the invention, the raw materials using relatively inexpensive and easy to obtain, the process route is mature, the operation is simple, high yield, and has high industrial value.
2,3,4,5-tetrahalogenobenzene derivatives
-
, (2008/06/13)
2,3,4,5-trihalogenobenzene derivatives of the formula STR1 in which R is --COOH, --COCl, --COF, --CN, --CONH2, --CH2 OH, --CH2 Cl, --CHCl2, --CCl3 or --CHO, R1 is H, Cl or F, and R2 is Cl or F, it only being possible for R1 or R2 to be F, and processes for their preparation starting from benzonitriles reacted with potassium fluoride. The novel compounds are intermediates for antibacterials such as quinolone carboxylic acids.